Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protocadherin 11 X-linked is a neuronal cell-adhesion molecule belonging to the protocadherin family within the cadherin superfamily. It features an extracellular domain with 7 cadherin repeats, a transmembrane region, and a cytoplasmic tail that differs from classical cadherins. Protocadherin 11 X-linked is widely expressed in the brain, playing a critical role in neural development by mediating cell–cell recognition, particularly important for the segmental organization and function of the central nervous system. Genetic alterations in this gene have been associated with neurodevelopmental and neuropsychiatric conditions, including developmental dyslexia, intellectual disability, and possibly Alzheimer’s disease; however, there is no consensus on its use as a therapeutic target or a disease biomarker. The gene has a human-specific Y chromosome paralog (PCDH11Y) that displays accelerated evolution and may have contributed to primate brain evolution and the neural substrates for language.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protocadherin 11 X-linked (PCDH11X).